Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Company Overview

Ampio Pharmaceuticals, Inc. is a clinical‐stage biopharmaceutical company focused on developing therapies that modulate the body’s inflammatory response to alleviate pain and improve functional outcomes. Headquartered in Englewood, Colorado, the company leverages proprietary plasma‐derived and synthetic formulations to target chronic musculoskeletal and cardiovascular conditions.

The company’s lead product candidate, Ampion, is a novel, low‐molecular‐weight fraction of human serum albumin designed as a single intra‐articular injection for patients suffering from osteoarthritis of the knee. Ampio is also advancing an intravenous formulation of this inflammation‐modulating technology for the treatment of acute cardiovascular injury and ischemia‐reperfusion damage. These programs are supported by preclinical studies and early‐stage clinical data demonstrating reduced inflammatory markers and improved tissue recovery.

Since its inception, Ampio has built a development‐stage portfolio under the leadership of President and Chief Executive Officer Mark A. Biancamano. The company’s management team combines expertise in biologics manufacturing, clinical trial operations and regulatory affairs. Ampio maintains partnerships with contract research organizations and specialized manufacturing sites to support its pipeline advancement.

Ampio Pharmaceuticals conducts its research and clinical activities primarily in the United States, collaborating with academic centers, clinical investigators and regulatory consultants. The company continues to pursue U.S. Food and Drug Administration guidance as it aims to transition its lead candidates from clinical development toward potential commercialization.

Key Stats

• Today's Range: $0.18 to $0.18
• 50-Day Range: $0.18 to $0.18
• 52-Week Range: $0.00 to $0.64
• Volume: N/A
• Average Volume: 2,326 shs
• Market Capitalization: $207.82 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/10/2021
• Today: 8/01/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NYSE:AMPE
• CIK: 1411906
• Web: ampiopharma.com
• Phone: 720-437-6500
• Fax: 720-437-6501
• Employees: 20
• Year Founded: 2010

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.04 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 1,135,000
• Free Float: 1,098,000
• Market Cap: $207.82 thousand
• Optionable: No Data
• Beta: 5.96